vs
Side-by-side financial comparison of ENvue Medical, Inc. (FEED) and SenesTech, Inc. (SNES). Click either name above to swap in a different company.
SenesTech, Inc. is the larger business by last-quarter revenue ($421.0K vs $312.0K, roughly 1.3× ENvue Medical, Inc.). SenesTech, Inc. runs the higher net margin — -428.5% vs -3919.6%, a 3491.0% gap on every dollar of revenue. On growth, SenesTech, Inc. posted the faster year-over-year revenue change (-16.0% vs -29.7%). SenesTech, Inc. produced more free cash flow last quarter ($-1.7M vs $-2.7M). Over the past eight quarters, SenesTech, Inc.'s revenue compounded faster (0.7% CAGR vs -41.8%).
ENvue Medical, Inc. is a medical technology firm specializing in advanced enteral feeding systems and related clinical support solutions. It serves healthcare providers, hospitals and long-term care facilities across North America, focusing on improving safety and efficiency of care for patients requiring enteral nutrition support.
SenesTech, Inc. is an agricultural biotechnology life-sciences company, specializing in fertility management as a form of pest control. The company's primary product, ContraPest is designed to make brown and black rats infertile. SenesTech is headquartered in Phoenix, Arizona.
FEED vs SNES — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $312.0K | $421.0K |
| Net Profit | $-12.2M | $-1.8M |
| Gross Margin | -118.6% | 55.3% |
| Operating Margin | -4748.1% | -446.8% |
| Net Margin | -3919.6% | -428.5% |
| Revenue YoY | -29.7% | -16.0% |
| Net Profit YoY | -754.6% | -43.7% |
| EPS (diluted) | $-28.73 | $0.48 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $312.0K | $421.0K | ||
| Q3 25 | $722.0K | $690.0K | ||
| Q2 25 | $494.0K | $625.0K | ||
| Q1 25 | $1.0M | $485.0K | ||
| Q4 24 | $444.0K | $501.0K | ||
| Q3 24 | $376.0K | $482.0K | ||
| Q2 24 | $817.0K | $459.0K | ||
| Q1 24 | $921.0K | $415.0K |
| Q4 25 | $-12.2M | $-1.8M | ||
| Q3 25 | $510.0K | $-1.3M | ||
| Q2 25 | $-4.0M | $-1.6M | ||
| Q1 25 | $-2.5M | $-1.7M | ||
| Q4 24 | $-1.4M | $-1.3M | ||
| Q3 24 | $-998.0K | $-1.5M | ||
| Q2 24 | $-688.0K | $-1.6M | ||
| Q1 24 | $-588.0K | $-1.8M |
| Q4 25 | -118.6% | 55.3% | ||
| Q3 25 | 26.2% | 62.8% | ||
| Q2 25 | -7.1% | 65.4% | ||
| Q1 25 | 36.0% | 64.5% | ||
| Q4 24 | 63.7% | 60.9% | ||
| Q3 24 | 35.4% | 65.4% | ||
| Q2 24 | 52.4% | 54.2% | ||
| Q1 24 | 72.1% | 32.5% |
| Q4 25 | -4748.1% | -446.8% | ||
| Q3 25 | -311.2% | -195.2% | ||
| Q2 25 | -804.9% | -258.2% | ||
| Q1 25 | -180.7% | -342.9% | ||
| Q4 24 | -308.6% | -250.9% | ||
| Q3 24 | -258.0% | -321.0% | ||
| Q2 24 | -82.5% | -349.0% | ||
| Q1 24 | -61.7% | -444.1% |
| Q4 25 | -3919.6% | -428.5% | ||
| Q3 25 | 70.6% | -188.1% | ||
| Q2 25 | -803.8% | -258.6% | ||
| Q1 25 | -243.4% | -343.3% | ||
| Q4 24 | -322.3% | -250.5% | ||
| Q3 24 | -265.4% | -313.9% | ||
| Q2 24 | -84.2% | -345.1% | ||
| Q1 24 | -63.8% | -441.4% |
| Q4 25 | $-28.73 | $0.48 | ||
| Q3 25 | $-0.91 | $-0.28 | ||
| Q2 25 | $-1.03 | $-0.87 | ||
| Q1 25 | $3.98 | $-1.28 | ||
| Q4 24 | $-108.94 | $-0.15 | ||
| Q3 24 | $-3.56 | $-2.07 | ||
| Q2 24 | $-27.18 | $-3.08 | ||
| Q1 24 | $2.38 | $-3.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.2M | $8.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $33.5M | $9.6M |
| Total Assets | $41.1M | $12.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.2M | $8.6M | ||
| Q3 25 | $7.0M | $10.2M | ||
| Q2 25 | $4.0M | $6.1M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | $752.0K | $1.3M | ||
| Q3 24 | $1.3M | $2.5M | ||
| Q2 24 | — | $2.0M | ||
| Q1 24 | — | $3.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.3M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $33.5M | $9.6M | ||
| Q3 25 | $42.5M | $11.3M | ||
| Q2 25 | $40.5M | $7.0M | ||
| Q1 25 | $35.7M | $2.9M | ||
| Q4 24 | $627.0K | $2.5M | ||
| Q3 24 | $1.9M | $3.7M | ||
| Q2 24 | $2.8M | $3.1M | ||
| Q1 24 | $3.5M | $4.6M |
| Q4 25 | $41.1M | $12.8M | ||
| Q3 25 | $54.4M | $14.6M | ||
| Q2 25 | $51.5M | $10.4M | ||
| Q1 25 | $44.1M | $3.6M | ||
| Q4 24 | $3.6M | $3.3M | ||
| Q3 24 | $4.7M | $4.4M | ||
| Q2 24 | $5.7M | $4.0M | ||
| Q1 24 | $6.2M | $5.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-1.7M |
| Free Cash FlowOCF − Capex | $-2.7M | $-1.7M |
| FCF MarginFCF / Revenue | -865.1% | -398.3% |
| Capex IntensityCapex / Revenue | 7.4% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-9.4M | $-5.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-1.7M | ||
| Q3 25 | $-2.0M | $-1.4M | ||
| Q2 25 | $-3.4M | $-1.1M | ||
| Q1 25 | $-1.3M | $-1.6M | ||
| Q4 24 | $-548.0K | $-1.2M | ||
| Q3 24 | $-836.0K | $-1.4M | ||
| Q2 24 | $-553.0K | $-1.6M | ||
| Q1 24 | $-579.0K | $-1.8M |
| Q4 25 | $-2.7M | $-1.7M | ||
| Q3 25 | $-2.0M | $-1.4M | ||
| Q2 25 | $-3.4M | $-1.2M | ||
| Q1 25 | $-1.3M | $-1.6M | ||
| Q4 24 | — | $-1.2M | ||
| Q3 24 | — | $-1.4M | ||
| Q2 24 | $-555.0K | $-1.6M | ||
| Q1 24 | $-580.0K | $-1.8M |
| Q4 25 | -865.1% | -398.3% | ||
| Q3 25 | -276.7% | -205.9% | ||
| Q2 25 | -685.6% | -191.5% | ||
| Q1 25 | -131.5% | -328.5% | ||
| Q4 24 | — | -246.1% | ||
| Q3 24 | — | -296.1% | ||
| Q2 24 | -67.9% | -354.2% | ||
| Q1 24 | -63.0% | -441.2% |
| Q4 25 | 7.4% | 3.1% | ||
| Q3 25 | 3.9% | 6.1% | ||
| Q2 25 | 0.8% | 7.5% | ||
| Q1 25 | 0.5% | 7.4% | ||
| Q4 24 | 0.0% | 3.0% | ||
| Q3 24 | 0.0% | 5.8% | ||
| Q2 24 | 0.2% | 8.5% | ||
| Q1 24 | 0.1% | 0.5% |
| Q4 25 | — | — | ||
| Q3 25 | -3.86× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
